Factors to be considered when assessing the burden of treatment and a patient’s capacity to cope with this workload are outlined.

Healthcare professionals would generally like to increase their electronic correspondence, yet most are currently faxing or posting their correspondence.

Beliefs about the usefulness of initiatives to reduce opioid prescribing in clinical practice and autonomy in prescribing may be important considerations in driving compliance.

This study compares virtual reality against standard care for children undergoing routine four-year-old immunisations.

Patients prescribed high doses of opioids need to be managed appropriately to reduce risks of morbidity and mortality.

Australia’s outdated definition of obesity likely hinders management and contributes to the observed gap between clinical guidelines and current practice.

This article explores the themes of patient choice, safety and optimising success in GP-led withdrawal. The four-step framework outlines how to best support patients to undertake a withdrawal.

Health coaching is an integral part of lifestyle medicine that can be used to facilitate behaviour change in key lifestyle areas.

It is important for prescribers to regularly ask patients about their medication adherence and to discuss strategies for promoting this.

Street-based general practice services are critical to facilitate easy access to primary and secondary management of chronic multimorbid conditions in marginalised patients.

Living with haemochromatosis is an individual journey that requires consistent, medically supported self-management guided by a positive attitude and awareness of the condition.

Patients and physicians need to be aware of the important implications that medical cannabis use may have for driving.

It is unlikely that medicinal cannabis will be used as a first-line agent for the management of pain, nausea and other specific symptoms, but it may have a complementary role within palliative care.

A woman aged 42 years presented with left-sided facial pain of three weeks’ duration.

Botulinum neurotoxin is an effective treatment for various movement disorders that are disabling and frequently under-recognised.